Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
Moderna reported Q2 2026 revenue of $145 million and a GAAP net loss of $(0.8) billion, or $(1.97) per share, while reiterating its target of up to 10% revenue growth for the full year. The company improved its 2026 operating expense outlook by approximately $0.2 billion and raised its year-end cash balance projection to $4.7-$5.2 billion, noting it paid $950 million in July for a prior litigation settlement.
Key figures
- Revenue
- 145000000
- Guidance
- 2026 revenue growth up to 10%; Opex outlook improved by ~$0.2B; year-end cash $4.7-5.2B
- Net loss
- $0.8 billion
- Rd expenses
- $651 million
- Cash balance
- $6.9 billion
- Litigation payment
- $950 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.